Retatrutide, developed by Soma, represents a promising development in weight control . This dual-action compound combines hormonal receptor properties with GIP receptor agonist stimulation , indicating substantial results in trial data for body improvement. Researchers believe this treatment is expected to offer a new pathway for people struggling